These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25310466)

  • 21. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
    de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
    Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified.
    Han B; Lim S; Yim J; Song YK; Koh J; Kim S; Lee C; Kim YA; Jeon YK
    J Pathol Transl Med; 2024 Mar; 58(2):59-71. PubMed ID: 38247153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.
    Yoo HY; Sung MK; Lee SH; Kim S; Lee H; Park S; Kim SC; Lee B; Rho K; Lee JE; Cho KH; Kim W; Ju H; Kim J; Kim SJ; Kim WS; Lee S; Ko YH
    Nat Genet; 2014 Apr; 46(4):371-5. PubMed ID: 24584070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.
    Fujisawa M; Sakata-Yanagimoto M; Nishizawa S; Komori D; Gershon P; Kiryu M; Tanzima S; Fukumoto K; Enami T; Muratani M; Yoshida K; Ogawa S; Matsue K; Nakamura N; Takeuchi K; Izutsu K; Fujimoto K; Teshima T; Miyoshi H; Gaulard P; Ohshima K; Chiba S
    Leukemia; 2018 Mar; 32(3):694-702. PubMed ID: 28832024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression.
    Paik JH; Koh J; Han B; Kim S; Lee KR; Lee S; Lee JO; Kim TM; Kim WY; Jeon YK
    Hum Pathol; 2023 Jan; 131():47-60. PubMed ID: 36495942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene.
    Liang PI; Chang ST; Lin MY; Hsieh YC; Chu PY; Chen CJ; Lin KJ; Jung YC; Hwang WS; Huang WT; Chang WC; Ye H; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(9):6097-107. PubMed ID: 25337257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas.
    Leclaire Alirkilicarslan A; Dupuy A; Pujals A; Parrens M; Vergier B; Robson A; Delfau-Larue MH; Ingen-Housz-Oro S; Chosidow O; Haioun C; Beylot-Barry M; Merlio JP; Copie-Bergman C; Gaulard P; Ortonne N
    Am J Surg Pathol; 2017 Dec; 41(12):1581-1592. PubMed ID: 28945625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice.
    Ng SY; Brown L; Stevenson K; deSouza T; Aster JC; Louissaint A; Weinstock DM
    Blood; 2018 Aug; 132(9):935-947. PubMed ID: 29769264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma.
    Ottolini B; Nawaz N; Trethewey CS; Mamand S; Allchin RL; Dillon R; Fields PA; Ahearne MJ; Wagner SD
    Blood Adv; 2020 Jun; 4(11):2392-2403. PubMed ID: 32484856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.
    Nguyen PN; Tran NTB; Nguyen TPX; Ngo TNM; Lai DV; Deel CD; Hassell LA; Vuong HG
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):431-438. PubMed ID: 33849798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
    Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma.
    Sakata-Yanagimoto M; Nakamoto-Matsubara R; Komori D; Nguyen TB; Hattori K; Nanmoku T; Kato T; Kurita N; Yokoyama Y; Obara N; Hasegawa Y; Shinagawa A; Chiba S
    Ann Hematol; 2017 Sep; 96(9):1471-1475. PubMed ID: 28634614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
    Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
    Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
    Fujisawa M; Chiba S; Sakata-Yanagimoto M
    J Clin Exp Hematop; 2017; 57(3):109-119. PubMed ID: 29279549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases.
    Zhan HQ; Li XQ; Zhu XZ; Lu HF; Zhou XY; Chen Y
    J Clin Pathol; 2011 Apr; 64(4):319-24. PubMed ID: 21330314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.
    Manso R; González-Rincón J; Rodríguez-Justo M; Roncador G; Gómez S; Sánchez-Beato M; Piris MA; Rodríguez-Pinilla SM
    Oncotarget; 2018 Mar; 9(22):16124-16133. PubMed ID: 29662631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion.
    Tsuboi Y; Iimura Y; Matsumura F; Nanmoku T; Suma S; Matsuoka R; Nakagawa T; Nakagawa D; Suehara Y; Hattori K; Sato K; Maruyama Y; Sakamoto T; Yokoyama Y; Kato T; Kurita N; Nishikii H; Obara N; Ieda M; Chiba S; Sakata-Yanagimoto M
    Intern Med; 2023 Feb; 62(4):595-600. PubMed ID: 35732446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RHOA mutation in follicular T-cell lymphoma: Clinicopathological analysis of 16 cases.
    Miyoshi H; Sakata-Yanagimoto M; Shimono J; Yoshida N; Hattori K; Arakawa F; Yanagida E; Takeuchi M; Yamada K; Suzuki T; Moritsubo M; Furuta T; Chiba S; Ohshima K
    Pathol Int; 2020 Sep; 70(9):653-660. PubMed ID: 32648273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
    Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
    Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of multicolor flow cytometry for circulating lymphoma cells and tests for the
    Hayashida M; Maekawa F; Chagi Y; Iioka F; Kobashi Y; Watanabe M; Ohno H
    Leuk Lymphoma; 2020 Oct; 61(10):2389-2398. PubMed ID: 32476550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.